Infectious Diseases Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Clinical Trial to Explore the Skin Test Dosage of EEC in People Aged 18 to 65 Years Old and the Safety and Preliminary Efficacy in People Aged 3 to 75 Years Old.
Conditions: Tuberculosis Interventions: Biological: 2.5 μg/ml EEC; Biological: 5μg/ml EEC; Biological: 5 unit（U） EC Sponsors: Chengdu CoenBiotech Co., Ltd; Beijing Chest Hospital, Capital Medical University; Wuhan Institute for Tuberculosis Control; The Public Health Clinical Center of Chengdu; Xuzhou Infectious Disease Hospital; Jiangsu Province Centers for Disease Control and Prevention; Changde First People ' s Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 11, 2024 Category: Research Source Type: clinical trials

A Long-term Observational Study Evaluating the Presentation and Management of Acute Respiratory Tract Infections in Primary Care Across Europe
Conditions: Acute Respiratory Tract Infection Sponsors: European Clinical Research Alliance for Infectious Diseases (ECRAID); UMC Utrecht; University of Oxford; Universiteit Antwerpen Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 28, 2024 Category: Research Source Type: clinical trials

Expanding Liver Transplant Immunosuppression Minimization Via Everolimus
Conditions: Liver Transplant Interventions: Drug: Everolimus; Drug: Tacrolimus (continued reduction); Drug: Tacrolimus (maintain 50% reduction); Drug: Everolimus Sponsors: National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 28, 2024 Category: Research Source Type: clinical trials

Impact of Long-acting Injectable Cabotegravir for HIV PrEP in MSM in France.
Conditions: Prevention Interventions: Drug: Cabotegravir Tablets, for oral use.; Drug: Cabotegravir Extended-Release Injectable Suspension, for intramuscular use.; Drug: Tenofovir disoproxil/Emtricitabine 300mg/200mg fixed-dose combination tablets, for oral use; Procedure: Rectal Biopsies Sponsors: ANRS, Emerging Infectious Diseases Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 23, 2024 Category: Research Source Type: clinical trials

Swab Testing to Optimize Pneumonia Treatment With Empiric Vancomycin
Conditions: Community-acquired Pneumonia Interventions: Diagnostic Test: MRSA Nasal Swab PCR Sponsors: Vanderbilt University Medical Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 22, 2024 Category: Research Source Type: clinical trials

A Clinical Trial in Adult Participants Without HIV and in Overall Good Health to Evaluate the Safety and Immunogenicity of CD4BS CH505M5 Pr-NP1 Followed by CH505 TF chTrimer Boost Both Adjuvanted With Either Lipid Nanoparticles (LNPs) or 3M-052-AF + Alum
Conditions: HIV Interventions: Biological: CD4BS CH505M5 Pr-NP1; Biological: CH505TF chTrimer; Biological: 3M-052-AF (labeled as AP 60-702); Biological: Aluminum Hydroxide Suspension (Alum); Biological: ACU-026-001-1 (labeled as empty LNP) Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); National Institutes of Health (NIH); Department of Health and Human Services; Duke University; Access to Advanced Health Institute (AAHI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 20, 2024 Category: Research Source Type: clinical trials

Fecal Microbiota Transplant National Registry
Conditions: Fecal Microbiota Transplant Sponsors: University of California, San Francisco; National Institute of Allergy and Infectious Diseases (NIAID) Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 16, 2024 Category: Research Source Type: clinical trials

Kidney Transplantation From Donors With HIV: Impact on Rejection and Long-Term Outcomes (Expanding HOPE Kidney)
Conditions: Hiv Interventions: Other: HIV D+/R+; Other: HIV D-/R+ Sponsors: Johns Hopkins University; National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 16, 2024 Category: Research Source Type: clinical trials

Expecting Mother's Study of Consumption or Avoidance of Peanut and Egg
Conditions: Allergy and Immunology; Peanut and Nut Allergy; Egg Allergy; Food Allergy in Infants; Food Allergy Peanut Interventions: Behavioral: Avoidance; Behavioral: Consumption Sponsors: University of Rochester; National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 15, 2024 Category: Research Source Type: clinical trials

Dynamics of Colonization and Infection by Multidrug-Resistant Pathogens in Immunocompromised and Critically Ill Patients
Conditions: Antimicrobial Drug Resistance; Antibiotic Resistant Infection; Clostridium Difficile; Carbapenem-Resistant Enterobacteriaceae Infection; Extended Spectrum Beta-Lactamase Producing Bacteria Infection; Vancomycin Resistant Enterococci Infection; Carbapenem Resistant Bacterial Infection; Vancomycin-Resistant Enterococcal Infection Sponsors: The Methodist Hospital Research Institute; National Institute of Allergy and Infectious Diseases (NIAID); M.D. Anderson Cancer Center; Baylor College of Medicine; University of Houston; William Marsh Rice University; The University of Texas Health Science Center, Houston Recrui...
Source: ClinicalTrials.gov - February 14, 2024 Category: Research Source Type: clinical trials

Safety and Immunogenicity of a Sub-unit Protein CD40.RBDv Bivalent COVID-19 Vaccine, Adjuvanted or Not, as a Booster in Volunteers.
Conditions: COVID-19 Interventions: Drug: CD40.RBDv vaccin (SARS-Cov2 Vaccin) Sponsors: ANRS, Emerging Infectious Diseases; LinKinVax; Vaccine Research Institute (VRI), France Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 13, 2024 Category: Research Source Type: clinical trials

pCCLCHIM-p47 (Lentiviral Vector Transduced CD34 Plus Cells) in Patients With p47 Autosomal Recessive Chronic Granulomatous Disease (AR-CGD)
Conditions: p47; Autosomal Recessive; Chronic Granulomatous Disease Interventions: Biological: Cryopreserved Autologous CD34+ cells transduced with pCCLCHIM-p47 Sponsors: National Institute of Allergy and Infectious Diseases (NIAID) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 12, 2024 Category: Research Source Type: clinical trials

Find HDV and Determine Its Status in Turkey
Conditions: Chronic Hepatitis D Infection With Hepatitis B Carrier State (Diagnosis); Fibrosis, Liver; Hepatocellular Carcinoma; Cirrhosis, Liver; Transmission Vertical Interventions: Diagnostic Test: Anti Delta Sponsors: Yasar Bay ındır; SOUTHEAST NEUROLOGY AND INFECTIOUS DISEASES SOCIETY; Gilead Sciences Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 8, 2024 Category: Research Source Type: clinical trials

Rapid De-escalation of Anti-MRSA Therapy Guided by S. Aureus Nares Screening in Case of Pneumonia
Conditions: Pneumonia, Bacterial Interventions: Diagnostic Test: MRSA nasal swab based de-escalation Sponsors: University of Bari Aldo Moro Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 2, 2024 Category: Research Source Type: clinical trials

Evaluation of Xpert MTB/RIF Ultra in Stools and Urine to Improve Tuberculosis Diagnosis in Children
Conditions: Tuberculosis; Pediatric Infectious Disease Interventions: Diagnostic Test: Xpert MTB/RIF Ultra in stools and urine Sponsors: Medecins Sans Frontieres, Spain; Ministry of Health, Guinea-Bissau; Ministry of Health, South Sudan; Institute of Tropical Medicine, University of Tuebingen Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 2, 2024 Category: Research Source Type: clinical trials